Pfizer CEO Albert Bourla promoted a fourth experimental vaccine dose during an appearance on Sunday’s CBS Face the Nation, despite acknowledging the jab’s short-lived “protection” and its inability to fight infection.
Pfizer CEO Albert Bourla promoted a fourth experimental vaccine dose during an appearance on Sunday’s CBS Face the Nation, despite acknowledging the jab’s short-lived “protection” and its inability to fight infection.